COMPARISON OF THE EFFECTS OF HIGH-DOSE TESTOSTERONE AND 19-NORTESTOSTERONE TO A REPLACEMENT DOSE OF TESTOSTERONE ON STRENGTH AND BODY-COMPOSITION IN NORMAL MEN

被引:47
作者
FRIEDL, KE [1 ]
DETTORI, JR [1 ]
HANNAN, CJ [1 ]
PATIENCE, TH [1 ]
PLYMATE, SR [1 ]
机构
[1] MADIGAN ARMY MED CTR,DEPT CLIN INVEST,TACOMA,WA 98431
关键词
D O I
10.1016/0960-0760(91)90283-B
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the extent to which supraphysiological doses of androgen can modify body composition and strength in normally virilized men. In doubly blind tests, 30 healthy young men received testosterone enanthate (TE) or 19-nortestosterone decanoate (ND), at 100 mg/wk or 300 mg/wk for 6 weeks. The TE-100 mg/wk group served as replacement dose comparison, maintaining pretreatment serum testosterone levels, while keeping all subjects blinded to treatment. particularly through reduction in testicular volumes. Isokinetic strength measurements were made for the biceps brachii and quadriceps femoris muscle groups before treatment and 2-3 days after the 6th injection. Small improvements were noted in all groups but the changes were highly variable; a trend to greater and more consistent strength gain occurred in the TE-300 mg/wk group. There was no change in weight for TE- 100 mg/wk but an average gain of 3 kg in each of the other groups. No changes in 4 skinfold thicknesses or in estimated percent body fat were observed. Of 15 circumferences. significant increases were observed only for men receiving TE-300 mg/wk (shoulders) and ND-300 mg/wk (shoulders and chest). The data suggest that high dose androgens increase body mass and may increase strength in normal men but, except for a consistent weight gain with greater than replacement doses, the detectable changes were highly variable and relatively small, especially in comparison to the significant alterations which were observed for other markers of androgen action.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 30 条
[1]   CHANGES IN NEUROMUSCULAR PERFORMANCE AND MUSCLE-FIBER CHARACTERISTICS OF ELITE POWER ATHLETES SELF-ADMINISTERING ANDROGENIC AND ANABOLIC-STEROIDS [J].
ALEN, M ;
HAKKINEN, K ;
KOMI, PV .
ACTA PHYSIOLOGICA SCANDINAVICA, 1984, 122 (04) :535-544
[2]   METHANDROSTENOLONE AND NANDROLONE DECANOATE IN MUSCULAR DYSTROPHY - A CONTROLLED TRIAL [J].
BARWICK, DD ;
WALTON, JN ;
NEWELL, DJ .
NEUROLOGY, 1963, 13 (01) :12-&
[3]   PHARMACOKINETICS OF 19-NORTESTOSTERONE ESTERS IN NORMAL MEN [J].
BELKIEN, L ;
SCHURMEYER, T ;
HANO, R ;
GUNNARSSON, PO ;
NIESCHLAG, E .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1985, 22 (05) :623-629
[4]  
BERGINK EW, 1985, ACTA ENDOCRINOL-COP, V110, P31
[5]   INFLUENCE OF NANDROLONDECANOATE ON THE PITUITARY-GONADAL AXIS IN MALES [J].
BIJLSMA, JWJ ;
DUURSMA, SA ;
THIJSSEN, JHH ;
HUBER, O .
ACTA ENDOCRINOLOGICA, 1982, 101 (01) :108-112
[6]   EFFECTS OF ANDROGENIC-ANABOLIC STEROIDS ON NEUROMUSCULAR POWER AND BODY-COMPOSITION [J].
CRIST, DM ;
STACKPOLE, PJ ;
PEAKE, GT .
JOURNAL OF APPLIED PHYSIOLOGY, 1983, 54 (02) :366-370
[7]   BODY FAT ASSESSED FROM TOTAL-BODY DENSITY AND ITS ESTIMATION FROM SKINFOLD THICKNESS - MEASUREMENTS ON 481 MEN AND WOMEN AGED FROM 16 TO 72 YEARS [J].
DURNIN, JVGA ;
WOMERSLEY, J .
BRITISH JOURNAL OF NUTRITION, 1974, 32 (01) :77-97
[8]   ANABOLIC STEROIDS IN ATHLETICS - CROSSOVER DOUBLE-BLIND TRIAL ON WEIGHTLIFTERS [J].
FREED, DLJ ;
BANKS, AJ ;
LONGSON, D ;
BURLEY, DM .
BRITISH MEDICAL JOURNAL, 1975, 2 (5969) :471-473
[9]  
FRIEDL KE, 1989, PHYSICIAN SPORTSMED, V17, P67, DOI 10.1080/00913847.1989.11709731
[10]   THE ADMINISTRATION OF PHARMACOLOGICAL DOSES OF TESTOSTERONE OR 19-NORTESTOSTERONE TO NORMAL MEN IS NOT ASSOCIATED WITH INCREASED INSULIN-SECRETION OR IMPAIRED GLUCOSE-TOLERANCE [J].
FRIEDL, KE ;
JONES, RE ;
HANNAN, CJ ;
PLYMATE, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (05) :971-975